UNSPSC 85613122: Supplement pancreatic duct with nonautologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement pancreatic duct with nonautologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0FUD3KZ

UNSPSC 85613122 Supplement pancreatic duct with nonautologous tissue substitute, percutaneous approach (Commodity) shows no relevant recent state and local procurement activity. The six most recent opportunities posted under this code span occupational medical surveillance, independent medical evaluations for public safety pension disability determinations, surgical benefit carve-out programs, emergency and specialty healthcare for detained youth, pharmacy benefit management, and temporary health professional staffing — none of which concern pancreatic duct supplementation or related surgical procedures. The code appears to be a clinical procedure descriptor misapplied to administrative healthcare and benefits procurement, indicating a tagging or taxonomy mismatch rather than genuine commodity-level activity in the state and local space.

No state or local government is currently soliciting pancreatic duct supplementation services, implants, or related materials under this code. Vendors pursuing state and local healthcare contracts should monitor clinical procedure codes only when opportunities explicitly reference those procedures in scope or statement of work; this code does not currently support a procurement pipeline.